Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Redeemable Preferred Stock and Stockholders' Equity (Unaudited)

v3.22.2
Consolidated Statements Of Redeemable Preferred Stock and Stockholders' Equity (Unaudited) - USD ($)
Total
Series F Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Convertible Preferred Stock
Series F Convertible Preferred Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Mezzanine Equity
Series G Redeemable Preferred Stock
Beginning balance at Dec. 31, 2020 $ 10,028,000   $ 4,000 $ 261,667,000   $ (385,000) $ (251,376,000)  
Beginning balance at Dec. 31, 2020         $ 118,000      
Beginning balance, shares at Dec. 31, 2020         1,000      
Balance (in shares) at Dec. 31, 2020     3,908,000          
Conversion of Series F Convertible Preferred Stock     $ 0 621,000 $ (621,000)      
Conversion of Series F Convertible Preferred Stock, shares     62,000   (1,000)      
Sale of common stock 13,291,000   $ 1,000 13,290,000        
Sale of common stock, shares     560,000          
Issuance of common stock for settlement of liability 510,000   $ 0 510,000        
Issuance of common stock for settlement of liability, Shares     20,000          
Deemed dividend on Series F Convertible Preferred Stock 538,000     (538,000) $ 538,000      
Stock-based compensation 2,062,000     2,062,000        
Issuance of stock from RSUs, net     $ 0 (0)        
Issuance of stock from RSUs, net, shares     71,000          
Exercise of common stock warrants 15,051,000   $ 1,000 15,050,000        
Exercise of common stock warrants, shares     1,428,000          
Net loss (7,603,000)           (7,603,000)  
Foreign currency translation adjustments (83,000)         (83,000)    
Ending balance at Jun. 30, 2021 33,256,000   $ 6,000 292,662,000   (468,000) (258,979,000)  
Ending Balance at Jun. 30, 2021         35,000      
Ending Balance (in shares) at Jun. 30, 2021     6,049,000          
Beginning balance at Mar. 31, 2021 33,516,000   $ 6,000 292,284,000   (533,000) (258,277,000)  
Beginning balance at Mar. 31, 2021         36,000      
Balance (in shares) at Mar. 31, 2021     5,977,000          
Conversion of Series F Convertible Preferred Stock       7,000 (7,000)      
Conversion of Series F Convertible Preferred Stock, shares     1,000          
Sale of common stock (1,000)     (1,000)        
Deemed dividend on Series F Convertible Preferred Stock 6,000     (6,000) 6,000      
Stock-based compensation 366,000     366,000        
Issuance of stock from RSUs, net     $ 0 (0)        
Issuance of stock from RSUs, net, shares     70,000          
Exercise of common stock warrants 12,000     12,000        
Exercise of common stock warrants, shares     1,000          
Net loss (702,000)           (702,000)  
Foreign currency translation adjustments 65,000         65,000    
Ending balance at Jun. 30, 2021 33,256,000   $ 6,000 292,662,000   (468,000) (258,979,000)  
Ending Balance at Jun. 30, 2021         35,000      
Ending Balance (in shares) at Jun. 30, 2021     6,049,000          
Beginning balance at Dec. 31, 2021 $ 25,208,000   $ 6,000 293,325,000   (623,000) (267,534,000)  
Beginning balance at Dec. 31, 2021         $ 34,000     $ 0
Beginning balance, shares at Dec. 31, 2021         0     0
Balance (in shares) at Dec. 31, 2021 6,855,000   6,149,000          
Issuance of Series G Redeemable Preferred Stock, shares               154,000
Conversion of Series F Convertible Preferred Stock     $ 0 251,000 $ (251,000)      
Conversion of Series F Convertible Preferred Stock, shares     25,000          
Deemed dividend on Series F Convertible Preferred Stock $ 217,000     (217,000) 217,000      
Stock-based compensation 611,000     611,000        
Issuance of stock from RSUs, net, shares     4,000          
Net loss (10,386,000)           (10,386,000)  
Foreign currency translation adjustments (263,000)         (263,000)    
Ending balance at Jun. 30, 2022 $ 21,615,000   $ 7,000 300,414,000   (886,000) (277,920,000)  
Ending Balance at Jun. 30, 2022         $ 0      
Ending Balance (in shares) at Jun. 30, 2022 6,857,000   6,857,000          
Ending balance, shares at Jun. 30, 2022   0     0      
Beginning balance at Mar. 31, 2022 $ 20,599,000   $ 6,000 293,567,000   (664,000) (272,310,000)  
Beginning balance at Mar. 31, 2022         $ 0     $ 0
Beginning balance, shares at Mar. 31, 2022         0     154,000
Balance (in shares) at Mar. 31, 2022     6,176,000          
Sale of common stock 5,849,000   $ 1,000 5,848,000        
Sale of common stock, shares     679,000          
Redemption of Series G Redeemable Preferred Stock, shares               154,000
Deemed dividend on Series F Convertible Preferred Stock 0              
Stock-based compensation 403,000     403,000        
Issuance of stock from RSUs, net, shares     2,000          
Liability award reclass 596,000     596,000        
Net loss (5,611,000)           (5,611,000)  
Foreign currency translation adjustments (222,000)         (222,000)    
Ending balance at Jun. 30, 2022 $ 21,615,000   $ 7,000 $ 300,414,000   $ (886,000) $ (277,920,000)  
Ending Balance at Jun. 30, 2022         $ 0      
Ending Balance (in shares) at Jun. 30, 2022 6,857,000   6,857,000          
Ending balance, shares at Jun. 30, 2022   0     0